OneMedNet (ONMD) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
OneMedNet insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $5.2M and 2 sold $321K of ONMD stock on the open market, including a cluster buy that began Jun 12, 2026.
Get emailed when insiders cluster-buy stocks like ONMD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ONMD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $1.1M | 2 | $103K | 5 |
| Q2 2026 | $1.6M | 9 | — | 0 |
| Q1 2026 | $500K | 1 | — | 0 |
| Q4 2025 | $30K | 1 | $218K | 2 |
| Q3 2025 | $765K | 19 | — | 0 |
| Q2 2025 | $1.2M | 4 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 OneMedNet Corp insiders reported open-market purchases totaling $5.2M, while 2 insiders reported sales totaling $321K. The most recent cluster buy began on Jun 12, 2026, when 3 insiders bought a combined $352K. Among insiders with enough purchase history to measure, Aaron Green (CEO) has the highest Insider Score at 73. 0 of 7 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ONMD stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 9 NewSEC | Aaron GreenCEO | Sell | 5,000249,638 held (−2%) | $7.39 | $37K | -41.8% | 73 |
| Oct 9 NewSEC | Robert Lawrence GoldenCFO | Sell | 3,00091,291 held (−3%) | $6.63 | $20K | -35.1% | — |
| Oct 9 NewSEC | Robert Lawrence GoldenCFO | Sell | 3,00094,291 held (−3%) | $6.30 | $19K | -31.7% | — |
| Oct 9 NewSEC | Robert Lawrence GoldenCFO | Sell | 2,50097,291 held (−3%) | $6.60 | $16K | -34.8% | — |
| Oct 9 NewSEC | Aaron GreenCEO | Sell | 1,667247,971 held (−1%) | $6.48 | $11K | -33.6% | 73 |
| Sep 14SEC | Jeffrey YuChief Medical Officer | Buy | 142,8578,923,267 held (+2%) | $0.63 | $90K | +582.5% | 8 |
| Aug 7SEC | Thomas KosasaDirector | Buy | 1,449,27518,538,150 held (+8%) | $0.69 | $1000K | +523.2% | 5 |
| Jun 24SEC | Jeffrey YuChief Medical Officer | Buy | 158,7308,780,410 held (+2%) | $0.63 | $100K | +582.5% | 8 |
| Jun 24SEC | Aaron GreenCEO | Buy | 36,6501,896,375 held (+2%) | $0.57 | $21K | +654.4% | 73 |
| Jun 17SEC | Jeffrey YuChief Medical Officer | Buy | 172,4148,621,680 held (+2%) | $0.58 | $100K | +641.4% | 8 |
| Jun 16SEC | Aaron GreenCEO | Buy | 36,9201,841,023 held (+2%) | $0.56 | $21K | +667.9% | 73 |
| Jun 16SEC | Aaron GreenCEO | Buy | 18,7021,859,725 held (+1%) | $0.54 | $10K | +696.3% | 73 |
| Jun 15SEC | Thomas KosasaDirector | Buy | 158,73017,088,874 held (+1%) | $0.63 | $100K | +582.5% | 5 |
| May 20SEC | Thomas KosasaDirector | Buy | 268,81716,930,144 held (+2%) | $0.93 | $250K | +362.4% | 5 |
| Apr 24SEC | Jeffrey YuChief Medical Officer | Buy | 903,6148,229,837 held (+12%) | $0.83 | $750K | +418.1% | 8 |
| Apr 24SEC | Thomas KosasaDirector | Buy | 595,23816,380,429 held (+4%) | $0.84 | $500K | +411.9% | 5 |
| Apr 24SEC | Thomas KosasaDirector | Buy | 280,89816,661,327 held (+2%) | $0.89 | $250K | +383.1% | 5 |
| Dec 23SEC | Aaron GreenCEO | Sell | 64,7671,865,658 held (−3%) | $2.23 | $144K | +92.8% | 73 |
| Dec 23SEC | Aaron GreenCEO | Sell | 61,5551,804,103 held (−3%) | $1.20 | $74K | +258.3% | 73 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,666,6666,737,410 held (+33%) | $0.42 | $700K | +923.8% | 8 |
| Nov 26SEC | Thomas KosasaDirector | Buy | 1,190,47615,152,796 held (+9%) | $0.42 | $500K | +923.8% | 5 |
| Nov 26SEC | Thomas KosasaDirector | Buy | 581,39515,734,191 held (+4%) | $0.86 | $500K | +400.0% | 5 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 173,3506,955,560 held (+3%) | $0.69 | $120K | +523.2% | 8 |
| Nov 26SEC | Eric CasaburiDirector | Buy | 10,00065,475 held (+18%) | $3.05 | $30K | +41.0% | — |
| Nov 26SEC | Thomas KosasaDirector | Buy | 47,0008,425,824 held (+1%) | $0.49 | $23K | +777.6% | 5 |
| Nov 26SEC | Thomas KosasaDirector | Buy | 55,0008,480,824 held (+1%) | $0.38 | $21K | +1031.6% | 5 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 24,3197,029,143 held (+0%) | $0.85 | $21K | +405.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 17,2007,079,973 held (+0%) | $1.02 | $18K | +321.6% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 21,3746,976,934 held (+0%) | $0.69 | $15K | +523.2% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 17,0006,993,934 held (+0%) | $0.80 | $14K | +437.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 16,5006,753,910 held (+0%) | $0.77 | $13K | +458.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 15,0006,768,910 held (+0%) | $0.77 | $12K | +458.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 11,8107,052,623 held (+0%) | $0.87 | $10K | +394.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 13,3006,782,210 held (+0%) | $0.75 | $10K | +473.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 11,6707,040,813 held (+0%) | $0.81 | $9K | +430.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 10,8907,004,824 held (+0%) | $0.82 | $9K | +424.4% | 8 |
| Nov 26SEC | Thomas KosasaDirector | Buy | 6,00015,740,191 held (+0%) | $0.93 | $6K | +362.4% | 5 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 5,7007,062,773 held (+0%) | $0.93 | $5K | +362.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 3,3002,458,424 held (+0%) | $1.31 | $4K | +228.2% | 8 |
| Nov 26SEC | Eric CasaburiDirector | Buy | 4,10053,675 held (+8%) | $0.92 | $4K | +367.4% | — |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 3,0402,461,494 held (+0%) | $1.06 | $3K | +305.7% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 5,3862,521,536 held (+0%) | $0.56 | $3K | +667.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 2,2372,529,789 held (+0%) | $1.19 | $3K | +261.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 5,0352,512,386 held (+0%) | $0.49 | $2K | +777.6% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,3572,524,243 held (+0%) | $1.45 | $2K | +196.6% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 2,1007,054,723 held (+0%) | $0.86 | $2K | +400.0% | 8 |
| Nov 26SEC | Eric CasaburiDirector | Buy | 2,00047,000 held (+4%) | $0.77 | $2K | +458.4% | — |
| Nov 26SEC | Eric CasaburiDirector | Buy | 2,00049,575 held (+4%) | $0.74 | $1K | +481.1% | — |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,2507,081,223 held (+0%) | $1.03 | $1K | +317.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 2,3042,516,150 held (+0%) | $0.55 | $1K | +681.8% | 8 |
| Nov 26SEC | Eric CasaburiDirector | Buy | 1,30055,475 held (+2%) | $0.87 | $1K | +394.3% | — |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,2507,056,673 held (+0%) | $0.89 | $1K | +383.1% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,6002,532,326 held (+0%) | $0.66 | $1K | +551.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 9132,527,552 held (+0%) | $1.10 | $1K | +290.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 9502,522,486 held (+0%) | $1.04 | $988 | +313.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 7007,055,423 held (+0%) | $0.91 | $637 | +372.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1,2032,526,639 held (+0%) | $0.52 | $626 | +726.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 8002,530,726 held (+0%) | $0.68 | $544 | +532.4% | 8 |
| Nov 26SEC | Robert Lawrence GoldenCFO | Buy | 300new position | $1.71 | $513 | +151.5% | — |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 4002,522,886 held (+0%) | $1.14 | $456 | +277.2% | 8 |
| Nov 26SEC | Eric CasaburiDirector | Buy | 50054,175 held (+1%) | $0.85 | $425 | +405.9% | — |
| Nov 26SEC | Eric CasaburiDirector | Buy | 57547,575 held (+1%) | $0.72 | $414 | +497.2% | — |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 7402,513,846 held (+0%) | $0.55 | $407 | +681.8% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 4007,057,073 held (+0%) | $0.95 | $380 | +352.6% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 7202,513,106 held (+0%) | $0.52 | $374 | +726.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 3622,462,291 held (+0%) | $0.61 | $221 | +604.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 3502,525,011 held (+0%) | $0.60 | $210 | +616.7% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1802,461,764 held (+0%) | $0.84 | $151 | +411.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 2142,525,225 held (+0%) | $0.65 | $139 | +561.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,529,926 held (+0%) | $1.22 | $122 | +252.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,763,195 held (+0%) | $0.99 | $99 | +334.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,461,874 held (+0%) | $0.86 | $86 | +400.0% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,524,345 held (+0%) | $0.82 | $82 | +424.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,524,461 held (+0%) | $0.79 | $79 | +444.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1052,525,436 held (+0%) | $0.69 | $72 | +523.2% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1062,525,331 held (+0%) | $0.68 | $72 | +532.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,524,561 held (+0%) | $0.65 | $65 | +561.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 1002,524,661 held (+0%) | $0.62 | $62 | +593.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 502,461,544 held (+0%) | $1.09 | $54 | +294.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 302,458,454 held (+0%) | $1.36 | $41 | +216.2% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 602,462,351 held (+0%) | $0.48 | $29 | +795.8% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 142,529,826 held (+0%) | $1.41 | $20 | +205.0% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 132,529,802 held (+0%) | $1.35 | $18 | +218.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 202,461,894 held (+0%) | $0.85 | $17 | +405.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 202,461,584 held (+0%) | $0.82 | $16 | +424.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 202,461,914 held (+0%) | $0.81 | $16 | +430.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 162,524,361 held (+0%) | $0.84 | $13 | +411.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 102,529,812 held (+0%) | $1.34 | $13 | +220.9% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 152,461,929 held (+0%) | $0.75 | $11 | +473.3% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 102,461,564 held (+0%) | $1.03 | $10 | +317.5% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 102,461,554 held (+0%) | $0.92 | $9 | +367.4% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 102,461,774 held (+0%) | $0.83 | $8 | +418.1% | 8 |
| Nov 26SEC | Jeffrey YuChief Medical Officer | Buy | 22,524,245 held (+0%) | $1.19 | $2 | +261.3% | 8 |
Insiders at OneMedNet Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Thomas KosasaDirector | $3.1M | — | Aug 7, 2026 | 5 |
| Jeffrey YuChief Medical Officer | $2.0M | — | Sep 14, 2026 | 8 |
| Aaron GreenCEO | $52K | $266K | Oct 9, 2026 | 73 |
| Eric CasaburiDirector | $39K | — | Nov 26, 2025 | — |
| Robert Lawrence GoldenCFO | $513 | $55K | Oct 9, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
ONMD stock: common questions
Are OneMedNet Corp insiders buying ONMD stock?
In the past 12 months, 4 insiders reported open-market purchases of ONMD worth $5.2M. The latest was Chief Medical Officer Jeffrey Yu bought $90K of ONMD at $0.63.
Are OneMedNet Corp insiders selling ONMD stock?
2 insiders reported sales worth $321K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ONMD's 52-week range?
Over the past year ONMD has traded between $4.30 and $31.40. It last closed at $4.30 on Oct 9, 2026.